Sort by
Refine Your Search
-
personal protection equipment (PPE). Your responsibilities will encompass developing new robotic benchmarking testing setup, hardware and controller of a robotic mechanical impactor, and data acquisition
-
, defensive mechanisms and related topics to the safe deployment of systems contain multiple LLM and VLM powered models. You will be responsible for Developing and implementing; capability evaluations, attacks
-
This is an exciting opportunity to join the Vyas Group , based in the MRC Molecular Haematology Unit , to conduct cutting-edge discovery research into the molecular and cellular mechanisms
-
institutions in the programme grant and with supporting industrial partners. About you You should possess a university PhD degree in mechanical engineering or a similar discipline, preferably with experience
-
and the concern that exposure to low frequency MFs may affect health. Whether the same or different mechanisms may be involved, is currently unknown. One mechanism has acquired experimental prominence
-
targets. You will join the Computational Rare Disease Genomics Team, who collectively use computational genomics to understand mechanisms underlying rare human disease to enhance diagnosis and treatment. We
-
, exploring computation on the quantum scale and executing calculations that reveal the fundamental structure of space and time. Reporting to the Head of Mecahnical Engineering Group, the Mechanical Workshop
-
computational genomics to understand mechanisms underlying rare human disease with a goal to enhance both diagnosis and treatment. We have a highly collaborative, open-science approach. As part of CRDG, you will
-
We are seeking to appoint a Postdoctoral Research Scientist in Transcriptomics of iPSC-Derived Neurons to join the newly established Oxford-GSK Institute for Molecular & Computational Medicine (IMCM
-
We are seeking an ambitious and highly motivated Research Assistant to work in a programme of research that aims to investigate extracellular vesicle biogenesis and biomarkers in Parkinson’s disease